Showing results (1711-1720 of 1,934) with videos related to
Sort By:
Pageof 194
Cancer Research|February 23, 2020
iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to RadiotherapyPatricia M R Pereira, Kimberly J Edwards, Komal Mandleywala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2021
Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET ProbePengju Nie, Teja Kalidindi, Veronica L Nagle, et al.Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric CancerPaul C Klauser, Gina Dehlavi, Michele De Franco, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumorFlorian Puls, Jodi M Carter, Nischalan Pillay, et al.Theriogenology|June 15, 2007
Placentation in cloned cattle: structure and microvascular architectureM A Miglino, F T V Pereira, J A Visintin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer modelEdwin C Pratt, David Bauer, Lukas M Carter, et al.Science (New York, N.Y.)|June 9, 2022
Robust variation in infant gut microbiome assembly across a spectrum of lifestylesMatthew R Olm, Dylan Dahan, Matthew M Carter, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In VivoHamid Reza Mirzaei, Samantha Lovibond, Leah Gajecki, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancerJoshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.Pageof 194